RDHL ▼ -4.3% - RedHill Biopharma Ltd. $RDHL RDHL RDHL - RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring's Rebyota® and Clenpiq® RedHill Biopharma announced it is acquiring commercialization rights to Ferring's Rebyota® and Clenpiq® in what the company described as a transformational deal, though the stock fell 4.3% today, suggesting investors may have concerns about the acquisition terms, financing requirements, or integration challenges despite the strategic rationale of expanding the company's commercial portfolio. 01-SEP-2026 07:00 AM ET